Compounds > aztreonam

aztreonam and rpx7009

aztreonam has been researched along with rpx7009 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's5 (100.00)2.80

Authors

AuthorsStudies
Clifton, MC; Griffith, DC; Hecker, SJ; Lomovskaya, O; Raja Reddy, K; Tarazi, Z; Totrov, M1
Chen, Y; Luo, Q; Qiu, Y; Shen, P; Xiao, Y; Xu, H; Yu, W1
Bianco, G; Boattini, M; Casale, R; Cavallo, R; Comini, S; Costa, C; Iannaccone, M1
Avison, MB; Dulyayangkul, P; Satapoomin, N1
Barnini, S; Falcone, M; Giordano, C; Leonildi, A; Suardi, LR; Tiseo, G1

Other Studies

5 other study(ies) available for aztreonam and rpx7009

ArticleYear
Broad-spectrum cyclic boronate β-lactamase inhibitors featuring an intramolecular prodrug for oral bioavailability.
    Bioorganic & medicinal chemistry, 2022, 05-15, Volume: 62

    Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Biological Availability; Prodrugs

2022
New options for bloodstream infections caused by colistin- or ceftazidime/avibactam-resistant Klebsiella pneumoniae.
    International journal of antimicrobial agents, 2021, Volume: 58, Issue:6

    Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Bacteremia; beta-Lactamase Inhibitors; Boronic Acids; Carbapenem-Resistant Enterobacteriaceae; Ceftazidime; Cilastatin; Colistin; Drug Combinations; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Tetracyclines

2021
Occurrence of multi-carbapenemases producers among carbapenemase-producing Enterobacterales and in vitro activity of combinations including cefiderocol, ceftazidime-avibactam, meropenem-vaborbactam, and aztreonam in the COVID-19 era.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2022, Volume: 41, Issue:4

    Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Bacterial Proteins; beta-Lactamases; Boronic Acids; Cefiderocol; Ceftazidime; Cephalosporins; COVID-19; Drug Combinations; Humans; Meropenem; Microbial Sensitivity Tests

2022
Klebsiella pneumoniae Mutants Resistant to Ceftazidime-Avibactam Plus Aztreonam, Imipenem-Relebactam, Meropenem-Vaborbactam, and Cefepime-Taniborbactam.
    Antimicrobial agents and chemotherapy, 2022, 04-19, Volume: 66, Issue:4

    Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Bacterial Proteins; beta-Lactamases; Borinic Acids; Boronic Acids; Carboxylic Acids; Cefepime; Ceftazidime; Drug Combinations; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests

2022
Meropenem/vaborbactam plus aztreonam for the treatment of New Delhi metallo-β-lactamase-producing Klebsiella pneumoniae infections.
    The Journal of antimicrobial chemotherapy, 2023, 09-05, Volume: 78, Issue:9

    Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Drug Combinations; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests

2023